Fabio Chianelli
Chief Executive Officer at PHARMATHER HOLDINGS LTD.
Net worth: 5 M $ as of 2024-03-30
Fabio Chianelli active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PHARMATHER HOLDINGS LTD. | Chief Executive Officer | 2019-12-31 | - |
| Chairman | 2019-12-31 | - | |
| DIAGNAMED HOLDINGS CORP. | Chairman | - | - |
| Chief Executive Officer | 2021-08-10 | - | |
| Director/Board Member | 2021-08-10 | - | |
| President | 2021-08-10 | - | |
Fabiotech, Inc.
 Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Corporate Officer/Principal | - | - |
Revive Therapeutics, Inc.
 Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The private company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Founder | - | - |
| President | - | - | |
Pharmather, Inc.
 Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Chief Executive Officer | - | - |
Career history of Fabio Chianelli
Former positions of Fabio Chianelli
| Companies | Position | Start | End |
|---|---|---|---|
| REVIVE THERAPEUTICS LTD. | Director/Board Member | 2012-03-26 | 2019-12-17 |
| Chief Executive Officer | 2012-03-26 | 2016-07-04 | |
| Founder | 2012-03-26 | 2019-12-17 | |
| President | 2016-07-04 | 2019-12-17 | |
| TITAN MEDICAL INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| General Counsel | - | - |
Training of Fabio Chianelli
| Toronto Metropolitan University of | Undergraduate Degree |
Statistics
International
| Canada | 9 |
Operational
| Chief Executive Officer | 4 |
| President | 3 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| TITAN MEDICAL INC. | Health Technology |
| REVIVE THERAPEUTICS LTD. | Health Technology |
| PHARMATHER HOLDINGS LTD. | Health Technology |
| DIAGNAMED HOLDINGS CORP. | Health Technology |
| Private companies | 3 |
|---|---|
Revive Therapeutics, Inc.
Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The private company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Health Technology |
Fabiotech, Inc.
Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Commercial Services |
Pharmather, Inc.
Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Fabio Chianelli
- Experience
